A Phase Ib/II, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of a Single Dose of LG00034053 Administered by Intra-articular Injection in Patients With Knee Osteoarthritis
This study is a multi-center, randomized, placebo-controlled, double-blind clinical study, consisting of Part 1 (Phase 1b) in a sequential, dose-escalating design and Part 2 (Phase 2) in a parallel design.
100 项与 LG-00034053 相关的临床结果
100 项与 LG-00034053 相关的转化医学
100 项与 LG-00034053 相关的专利(医药)
100 项与 LG-00034053 相关的药物交易